國家衛生研究院 NHRI:Item 3990099045/1154
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 12145/12927 (94%)
造访人次 : 913034      在线人数 : 1181
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻
    主页 ‧ 登入 ‧ 上传 ‧ 说明 ‧ 关于NHRI ‧ 管理 到手机版


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/1154


    题名: Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide
    作者: Wu, CJ;Jan, JT;Chen, CM;Hsieh, HP;Hwang, DR;Liu, HW;Liu, CY;Huang, HW;Chen, SC;Hong, CF;Lin, RK;Chao, YS;Hsu, JTA
    贡献者: Division of Biotechnology and Pharmaceutical Research
    摘要: Antiviral agents are urgently needed to fight severe acute respiratory syndrome (SARS). We showed that niclosamide, an existing antihelminthic drug, was able to inhibit replication of a newly discovered coronavirus, SARS-CoV; viral antigen synthesis was totally abolished at a niclosamide concentration of 1.56 muM, as revealed by immunoblot analysis. Thus, niclosamide represents a promising drug candidate for the effective treatment of SARS-CoV infection.
    关键词: Microbiology;Pharmacology & Pharmacy
    日期: 2004-07
    關聯: Antimicrobial Agents and Chemotherapy. 2004 Jul;48(7):2693-2696.
    Link to: http://dx.doi.org/10.1128/AAC.48.7.2693-2696.2004
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0066-4804&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000222427200049
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=3042675488
    显示于类别:[徐祖安] 期刊論文
    [謝興邦] 期刊論文
    [趙宇生(2002-2013)] 期刊論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    000222427200049.pdf351KbAdobe PDF356检视/开启


    在NHRI中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈